Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretic therapy or those with conditions predisposing to potassium loss. ## Adult Dosing * **Oral Replacement:** Doses vary widely based on severity of hypokalemia and clinical status. * **Mild to moderate hypokalemia:** 20-60 mEq per day, divided into 1-3 doses. * **Severe hypokalemia (serum K < 2.5 mEq/L) or ECG changes:** May require higher doses, up to 100-200 mEq per day, often administered intravenously. * **Maintenance:** 20-40 mEq per day. * **Intravenous (IV) Replacement:** * **General Replacement (serum K 3.0-3.4 mEq/L):** 10-20 mEq IV infused over 1-2 hours. * **Moderate Hypokalemia (serum K 2.5-2.9 mEq/L):** 20-40 mEq IV infused over 2-4 hours. * **Severe Hypokalemia (serum K < 2.5 mEq/L):** 40-100 mEq IV may be administered over 4-10 hours. Higher doses may be needed but require very close monitoring. * **Maximum infusion rate:** Generally **10-20 mEq/hour** in peripheral lines. Higher rates (up to 40 mEq/hour) may be used in critical care settings with continuous cardiac monitoring and central venous access. **Rapid IV infusion of concentrated potassium solutions can be fatal.** * **Maximum concentration:** Peripheral IV: **40 mEq/L**. Central IV: **100 mEq/L** (though often limited to 80 mEq/L due to phlebitis risk). ## Pediatric Dosing * Dosing varies based on age, weight, and severity of hypokalemia. Local protocols should be consulted. * **Oral Replacement:** Typical maintenance dose is 1-2 mEq/kg/day, divided into doses. Repletion doses can be higher, up to 3-5 mEq/kg/day, not to exceed adult maximums. * **Intravenous (IV) Replacement:** * **General guideline:** 0.5-1 mEq/kg/dose, infused over 1-3 hours. * **Total daily dose:** Typically 20-40 mEq/kg/day, not to exceed 100-200 mEq/day for infants and children, or adult maximums. * **Maximum infusion rate:** Typically **0.5-1 mEq/kg/hour**, not to exceed 20 mEq/hour in neonates and infants. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dose reduction is necessary. Monitor potassium levels closely. In severe renal impairment, potassium supplementation may be contraindicated. ## Contraindications * Hyperkalemia. * Conditions causing generalized cellular destruction (e.g., severe burns, extensive trauma), as these can lead to hyperkalemia. * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence. * **Serious:** Hyperkalemia (especially with rapid IV infusion, renal impairment, or concomitant potassium-sparing drugs), cardiac arrhythmias, cardiac arrest, phlebitis (with IV administration), gastrointestinal ulceration or bleeding (with oral administration, particularly if not taken with sufficient fluid or if enteric-coated preparations are used). ## Key Drug Interactions * **ACE inhibitors, ARBs, potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), NSAIDs, heparin, trimethoprim:** Increase the risk of hyperkalemia. * **Loop and thiazide diuretics:** Can cause hypokalemia, increasing the need for potassium replacement. However, concomitant use requires careful monitoring as it can also mask hypokalemia in the face of other potassium-losing conditions. * **Insulin:** Can shift potassium into cells, potentially masking hypokalemia temporarily. ## Monitoring * **Serum potassium levels:** Essential, especially with IV administration, dose changes, renal impairment, or concurrent interacting medications. Frequency depends on clinical status and route of administration. * **ECG:** Recommended for severe hypokalemia or rapid IV infusion to detect cardiac changes (e.g., flattened T waves, prolonged QT interval, arrhythmias). * **Renal function (BUN, creatinine):** To assess risk of potassium accumulation. * **Fluid and electrolyte balance:** Monitor other electrolytes (sodium, magnesium) and acid-base status. ## Clinical Pearls * Oral potassium chloride should always be taken with a full glass of water or juice to minimize gastrointestinal irritation and risk of esophageal ulceration. * Dilute IV potassium chloride appropriately to avoid phlebitis and ensure safe administration rates. * Be aware that symptoms of hypokalemia and hyperkalemia can be similar (e.g., weakness, fatigue, arrhythmias). * Consider the underlying cause of hypokalemia; treating the cause is crucial for long-term management. * Enteric-coated or sustained-release formulations are associated with a higher risk of gastrointestinal adverse effects. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical judgment. Always consult the most current prescribing information or product monograph for complete details and to ensure accuracy before making any treatment decisions. Dosing and recommendations may vary based on specific patient factors and local institutional protocols.